Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b)

被引:76
|
作者
Kuijpers, TW
Maianski, NA
Tool, ATJ
Smit, GPA
Rake, JP
Roos, D
Visser, G
机构
[1] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Sanquin Res Cent Lab Blood Transfus, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Groningen Hosp, Beatrix Children Hosp, Groningen, Netherlands
[5] Univ Utrecht, Wilhelmina Childrens Hosp, Med Ctr, Utrecht, Netherlands
关键词
D O I
10.1182/blood-2002-10-3128
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glycogen storage disease type 1b (GSD1b) is a rare autosomal recessive disorder characterized by hypoglycemia, hepatomegaly, and growth retardation, and associated-for unknown reasons-with neutropenia and neutrophil dysfunction. In 5 GSD1b patients in whom nicotinamide adenine dinucleotide phosphate-oxidase activity and chemotaxis were defective, we found that the majority of circulating granulocytes bound Annexin-V. The neutrophils showed signs of apoptosis with increased caspase activity, condensed nuclei, and perinuclear clustering of mitochondria to which the proapoptotic Bcl-2 member Bax had translocated already. Granulocyte colony-stimulating factor (G-CSF) addition to in vitro cultures did not rescue the GSD1b neutrophils from apoptosis as occurs with G-CSF-treated control neutrophils. Moreover, the 2 GSD1b patients on G-CSF treatment did not show significantly lower levels of apoptotic neutrophils in the bloodstream. Current understanding of neutrophil apoptosis and the accompanying functional demise suggests that GSD1b granulocytes are dysfunctional because they are apoptotic. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:5021 / 5024
页数:4
相关论文
共 50 条
  • [21] ORAL MANIFESTATIONS IN GLYCOGEN-STORAGE-DISEASE TYPE 1B
    SALAPATA, Y
    LASKARIS, G
    DROGARI, E
    HAROKOPOS, E
    MESSARITAKIS, J
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1995, 24 (03) : 136 - 139
  • [22] MULTIPLE TRANSPORT PROTEIN DEFECTS IN A PATIENT WITH GLYCOGEN-STORAGE-DISEASE TYPE-1 - GSD 1B/1C(BETA)
    HAWKINS, RA
    KAMATH, KR
    SCOTT, HM
    BURCHELL, A
    JOURNAL OF INHERITED METABOLIC DISEASE, 1995, 18 (05) : 558 - 566
  • [23] LONG-TERM TREATMENT OF GLYCOGEN-STORAGE-DISEASE TYPE 1B (GSD 1B) WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM/CSF)
    BURLINA, AB
    BORDUGO, A
    PIVA, E
    DARIOL, R
    ZACCHELLO, F
    PEDIATRIC RESEARCH, 1994, 35 (02) : 283 - 283
  • [24] Normoglycaemia in Type 1b glycogen storage disease with difficult venous access
    Hammond, S.
    Krol, A.
    Hampson-Evans, D.
    ANAESTHESIA, 2009, 64 (10) : 1150 - 1150
  • [25] Prolonged survival of hepatocytes transplanted for glycogen storage disease type 1B
    Lee, Sanghoon
    Lee, Ji-Hyun
    Park, Hey-Jung
    Kim, Young-A
    Park, Mi-Na
    Lee, Suk-Koo
    XENOTRANSPLANTATION, 2015, 22 : S130 - S130
  • [26] Living Donor Liver Transplantation for Glycogen Storage Disease Type 1b
    Kasahara, Mureo
    Horikawa, Reiko
    Sakamoto, Seisuke
    Shigeta, Takanobu
    Tanaka, Hideaki
    Fukuda, Akinari
    Abe, Kiyomi
    Yoshii, Keisuke
    Naiki, Yasuhiro
    Kosaki, Rika
    Nakagawa, Atsuko
    LIVER TRANSPLANTATION, 2009, 15 (12) : 1867 - 1871
  • [27] SCT for Secondary AML in a Patient with Glycogen Storage Disease Type 1b
    Zeidler, Cornelia
    Kafa, Kinan
    Sauer, Martin G.
    Maecker-Kolhoff, Britta
    Greil, Johann
    Welte, Karl
    Kratz, Christian P.
    Sykora, Karl-Walter
    BLOOD, 2012, 120 (21)
  • [28] Clinical course and outcome of glycogen-storage disease type 1a and type 1b
    Eminoglu, Fatma Tuba
    Tumer, Leyla
    Okur, Ilyas
    Ezgu, Fatih Suheyl
    Hasanoglu, Alev
    TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2013, 48 (02): : 117 - 122
  • [29] Acute myelogenous leukemia and glycogen storage disease 1b
    Pinsk, M
    Burzynski, J
    Yhap, M
    Fraser, RB
    Cummings, B
    Ste-Marie, M
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (09) : 756 - 758
  • [30] Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patients
    Hexner-Erlichman, Zufit
    Veiga-da-Cunha, Maria
    Zehavi, Yoav
    Vadasz, Zahava
    Sabag, Adi D.
    Tatour, Sameh
    Spiegel, Ronen
    FRONTIERS IN PEDIATRICS, 2022, 10